Nohla Therapeutics is a cellular therapy company driven to provide leading off the shelf therapies for patients with critical diseases. Nohla’s first product is a universal donor cell therapy targeting hematopoietic recovery and chemotherapy induced neutropenia, and is being extended to treat a range of other medical indications. This and other products in the pipeline are based on a unique umbilical cord blood expansion platform developed at the Fred Hutchinson Cancer Research Center
View Top Employees from Nohla Therapeutics| Website | http://nohlatherapeutics.com |
| Revenue | $9.8 million |
| Funding | $118.4 million |
| Employees | 29 (5 on RocketReach) |
| Founded | 2015 |
| Address | 1616 Eastlake Ave. E Ste. 202, Seattle, Washington 98102, US |
| Phone | (206) 519-5300 |
| Technologies | |
| Industry | Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Health Diagnostics, Health Care, Therapeutics |
| Web Rank | 14 Million |
| Keywords | Nohla, Nohlatherapeutics, Nohla Therapeutics, Mustang Bio |
| Competitors | Adaptimmune, Juno Therapeutics, Inc., Kite Pharma, VGX Pharmaceuticals |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Nohla Therapeutics employee's phone or email?
Nohla Therapeutics Questions
The Nohla Therapeutics annual revenue was $9.8 million in 2024.
Tom Swallow is the Vice President, Finance and Administration of Nohla Therapeutics.
5 people are employed at Nohla Therapeutics.
Nohla Therapeutics is based in Seattle, Washington.
The NAICS codes for Nohla Therapeutics are [325, 32, 3254].
The SIC codes for Nohla Therapeutics are [283, 28].
Top Nohla Therapeutics Employees
-
ViewTom Swallow
Vice President, Finance and Administration at Nohla Therapeutics
Seattle, Washington, United States44 -
1
Related Companies
